
News|Articles|December 9, 2024
Recap Key Industry Trends for Viral Clearance and NGS
Author(s)Charles River
Learn highlights from the 2024 event, including new strategies for viral clearance and NGS applications for viral safety testing.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
2
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
3
Speed-to-IND Starts with Toxicology: A Rapid-Fire Q&A with Lonza
4
Ivonescimab Breakthrough Designation Highlights Progress in BTC Treatment
5